Search for other papers by Xue-Jiao Yang in
Google Scholar
PubMed
Search for other papers by Le-Yang Zhang in
Google Scholar
PubMed
Search for other papers by Qing-Hua Ma in
Google Scholar
PubMed
Search for other papers by Hong-Peng Sun in
Google Scholar
PubMed
Search for other papers by Yong Xu in
Google Scholar
PubMed
Search for other papers by Xing Chen in
Google Scholar
PubMed
Search for other papers by Chen-Wei Pan in
Google Scholar
PubMed
Introduction Metabolic syndrome (MetS) affects about one-fourth of the global adult population. The prevalence of MetS has been increasing rapidly in the mainland of China over the past few decades ( 1 ), reaching 33.9% (31.0% in men and 36
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Cornelia Then in
Google Scholar
PubMed
Search for other papers by Holger Then in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Search for other papers by Andreas Lechner in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
Search for other papers by Cornelia Huth in
Google Scholar
PubMed
Chair of Epidemiology at UNIKAT Augsburg, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Christa Meisinger in
Google Scholar
PubMed
KORA Study Center, University Hospital Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
Search for other papers by Wolfgang Rathmann in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Christian Herder in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Michael Roden in
Google Scholar
PubMed
Search for other papers by Jürgen Scherberich in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Jochen Seissler in
Google Scholar
PubMed
Introduction The metabolic syndrome is associated with an increased risk for cardiovascular and renal complications, and chronic renal failure in metabolic syndrome may progress to end-stage renal disease ( 1 , 2 ). Kidney pathophysiological
Search for other papers by Antonia Ertelt in
Google Scholar
PubMed
Search for other papers by Ann-Kristin Barton in
Google Scholar
PubMed
Search for other papers by Robert R Schmitz in
Google Scholar
PubMed
Search for other papers by Heidrun Gehlen in
Google Scholar
PubMed
Introduction Metabolic syndrome in humans was first described almost 50 years ago by Camus (1) , but there was little interest in this disease until the late 1980s, when it gained new attention as ‘syndrome X’ or ‘the deadly quartet’ (2, 3
Search for other papers by Małgorzata Kałużna in
Google Scholar
PubMed
Search for other papers by Agnieszka Nomejko in
Google Scholar
PubMed
Search for other papers by Aleksandra Słowińska in
Google Scholar
PubMed
Search for other papers by Katarzyna Wachowiak-Ochmańska in
Google Scholar
PubMed
Search for other papers by Katarzyna Pikosz in
Google Scholar
PubMed
Search for other papers by Katarzyna Ziemnicka in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a common condition, affecting up to 20% of reproductive-aged women ( 1 , 2 ). PCOS is associated with significant hormonal, reproductive , metabolic, and psychological concerns. PCOS is
Search for other papers by V G Pluimakers in
Google Scholar
PubMed
Search for other papers by M van Waas in
Google Scholar
PubMed
Search for other papers by C W N Looman in
Google Scholar
PubMed
Search for other papers by M P de Maat in
Google Scholar
PubMed
Search for other papers by R de Jonge in
Google Scholar
PubMed
Search for other papers by P Delhanty in
Google Scholar
PubMed
Search for other papers by M Huisman in
Google Scholar
PubMed
Search for other papers by F U S Mattace-Raso in
Google Scholar
PubMed
Search for other papers by M M van den Heuvel-Eibrink in
Google Scholar
PubMed
Section Endocrinology, Department of Medicine, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by S J C M M Neggers in
Google Scholar
PubMed
disease interact and cluster together as metabolic syndrome ( 6 , 7 , 8 ). In order to prevent the development of diabetes mellitus and cardiovascular disease, it is important to identify survivors at risk of developing (components of) MetS and to
Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
Search for other papers by Milica Popovic in
Google Scholar
PubMed
Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
Search for other papers by Fahim Ebrahimi in
Google Scholar
PubMed
Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
Search for other papers by Sandrine Andrea Urwyler in
Google Scholar
PubMed
Department of Biomedicine, University of Basel, Basel, Switzerland
Search for other papers by Marc Yves Donath in
Google Scholar
PubMed
Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland
Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Introduction Patients with metabolic syndrome are at significant risk for developing type 2 diabetes mellitus and cardiovascular diseases ( 1 ). Arginine vasopressin (AVP) was suggested to play a causal role in the development of type 2
Search for other papers by Ling Hu in
Google Scholar
PubMed
Search for other papers by Ting Li in
Google Scholar
PubMed
Search for other papers by Xiao-Ling Yin in
Google Scholar
PubMed
Search for other papers by Yi Zou in
Google Scholar
PubMed
consciousness in general, the detection rate of thyroid nodules has increased ( 4 ). Metabolic syndrome (MS) is characterized by the presence of at least four of the following clinical components: hyperglycemia, abdominal obesity, atherogenic dyslipidemia (low
Search for other papers by Nicolás Crisosto in
Google Scholar
PubMed
Search for other papers by Bárbara Echiburú in
Google Scholar
PubMed
Search for other papers by Manuel Maliqueo in
Google Scholar
PubMed
Search for other papers by Marta Luchsinger in
Google Scholar
PubMed
Search for other papers by Pedro Rojas in
Google Scholar
PubMed
Search for other papers by Sergio Recabarren in
Google Scholar
PubMed
Search for other papers by Teresa Sir-Petermann in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is a common familial endocrine-metabolic disorder that affects women of reproductive age, characterized by irregular menses, chronic anovulation, infertility and hyperandrogenism ( 1 , 2 ). A
School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China
Search for other papers by Xinyuan Zhang in
Google Scholar
PubMed
Search for other papers by Suiyan Li in
Google Scholar
PubMed
Search for other papers by Hongwei Liu in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
.fertnstert.2015.02.024 ) 28 Zhang J Fan P Liu H Bai H Wang Y & Zhang F . Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS . Human Reproduction 2012 27 2484 – 2493 . ( https://doi.org/10
Search for other papers by Sandra N Slagter in
Google Scholar
PubMed
Search for other papers by Robert P van Waateringe in
Google Scholar
PubMed
Search for other papers by André P van Beek in
Google Scholar
PubMed
Search for other papers by Melanie M van der Klauw in
Google Scholar
PubMed
Search for other papers by Bruce H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by Jana V van Vliet-Ostaptchouk in
Google Scholar
PubMed
Introduction The metabolic syndrome (MetS) is nowadays frequently used to identify individuals at higher risk for future type 2 diabetes (T2D) and cardiovascular disease (CVD) ( 1 ). Recognized metabolic risk components are abdominal obesity